Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies
出版年份 2022 全文链接
标题
Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies
作者
关键词
-
出版物
Vaccines
Volume 10, Issue 5, Pages 763
出版商
MDPI AG
发表日期
2022-05-13
DOI
10.3390/vaccines10050763
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society
- (2021) Monika Nojszewska et al. Neurologia i Neurochirurgia Polska
- Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?
- (2021) Charles Shey Wiysonge et al. Human Vaccines & Immunotherapeutics
- COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
- (2021) Anat Achiron et al. Multiple Sclerosis Journal
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic
- (2021) Abanoub Riad et al. Journal of Clinical Medicine
- Adverse Events After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease
- (2021) Gregory J. Botwin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel
- (2021) Itay Lotan et al. EUROPEAN JOURNAL OF NEUROLOGY
- Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient
- (2021) Masoud Etemadifar et al. Human Vaccines & Immunotherapeutics
- Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report
- (2021) Giorgia T. Maniscalco et al. Frontiers in Neurology
- Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers
- (2021) Miloslav Klugar et al. Biology-Basel
- Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
- (2021) Fioravante Capone et al. Neurotherapeutics
- Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study
- (2021) Jorge Antonio Esquivel-Valerio et al. RHEUMATOLOGY INTERNATIONAL
- Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England
- (2021) Afagh Garjani et al. Multiple Sclerosis and Related Disorders
- Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives
- (2020) Angelika Wagner et al. Frontiers in Immunology
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started